Group Action Lawyers
Latest News & Updates

Tag: medical recall

eye claims
September 07, 2018
Latanoprost Timolol eye drops recall

A Latanoprost Timolol eye drops recall has been announced by the Medicines and Healthcare Regulatory Authority (MHRA).

The company behind the eye drops, FDC Pharma, are recalling a batch due to what has been classed as an ‘out of specification result for an unknown impurity’ that was identified during testing. Medical professionals are to stop providing the eye drops to patients, and suppliers and distributors are to cease moving the eye drops as well.

The NHS has been pushing the news throughout the Service to ensure batches affected by the Latanoprost Timolol eye drops recall are not used.

Continue Reading…

hernia mesh compensation claims
August 31, 2018
Compensation for pelvic mesh problems

You can claim for personal injury compensation for pelvic mesh problems, and it’s important to claim given the severity of the issues that can arise.

We’ve spent a number of years talking about pelvic mesh problems, and we’re now at a point where the number of people suffering complications appears to be increasing, and people are far more aware of the dangers now. Only recently did the NHS finally put a widespread pause on the procedure – news we welcome – after another review into the safety and the efficacy of the devices.

With some victims left unable to walk or work for the rest of their lives, claiming compensation for personal injury and losses is incredibly important.

Continue Reading…

unsatisfactory safety information
July 19, 2018
Phenytoin 90mg/5ml Oral Suspension immediate discontinuation

There has been an immediate discontinuation of unlicensed medicine Phenytoin 90mg/5ml Oral Suspension and a recall of the product.

The medication, manufactured by Rosemont Pharmaceuticals Limited, is now no longer on the shelves having been recalled and discontinued with immediate affect as a result of worrying data that suggested that the medication becomes difficult to resuspend over shelf-life.

Patients who use the Phenytoin 90mg/5ml Oral Suspension are being told to contact their doctors for more information and advice about the issues that have been identified.

Continue Reading…

medical alert
July 04, 2018
Roche Diabetes Care test strip errors leads to recall

Roche Diabetes Care test strip errors has led to a recall of a number of home-use and point-of-care glucose monitoring systems.

The Roche Diabetes Care test strip errors are for the following systems: Accu-Chek Aviva; Accu-Chek Performa; and Accu-Chek Inform II.

There is a risk of a strip error message that may lead to either falsely high or falsely low blood glucose results reported.

Continue Reading…

drug recall
April 13, 2018
Cancer drug recall confirmed by UK regulators

A cancer drug recall has been initiated due to reports of excessive levels of an active ingredient used in the drug.

Pharmaceutical company AstraZeneca UK has initiated the recall, primarily for batch NG327, because the “level of olaparib polymorphic form L exceeds the registered specification limit”.

As well as the batch being recalled above, there are other batches that are a part of the recall as well, which is all said to be a part of a precautionary measure.
Continue Reading…